TABLE 1.
Background characteristics of the participants.
| Placebo (Mean ± SD) | NMN (Mean ± SD) | p-Value | |
| Sex (female/male) | 11/4 | 11/4 | – |
| Age (years old) | 43.9 ± 9.9 | 42.9 ± 12.0 | 0.92 |
| Height (cm) | 163.0 ± 8.5 | 162.3 ± 7.2 | 0.85 |
| Body weight (kg) | 56.2 ± 7.7 | 56.3 ± 8.6 | 0.97 |
| BMI (kg/m2) | 21.1 ± 2.1 | 21.3 ± 2.5 | 0.90 |
| Body fat% (%) | 25.6 ± 5.7 | 25.7 ± 5.0 | 0.92 |
| Systolic BP (mmHg) | 123.3 ± 10.7 | 121.1 ± 6.2 | 0.48 |
| Diastolic BP (mmHg) | 74.5 ± 7.5 | 74.3 ± 8.9 | 0.84 |
| Pulse rate (bpm) | 76.4 ± 8.9 | 76.2 ± 11.9 | 0.68 |
| AST (IU/L) | 19.7 ± 3.4 | 19.5 ± 5.2 | 0.66 |
| ALT (IU/L) | 17.3 ± 7.1 | 17.8 ± 10.8 | 0.56 |
| γGT (IU/L) | 17.7 ± 6.2 | 17.0 ± 9.4 | 0.31 |
| Amylase (U/L) | 92.1 ± 41.4 | 91.9 ± 29.0 | 0.82 |
| Triglyceride (mg/dL) | 66.5 ± 19.4 | 66.7 ± 19.2 | 0.95 |
| LDL-cholesterol (mg/dL) | 106.6 ± 17.3 | 105.2 ± 24.7 | 0.76 |
| Glucose (mg/dL) | 98.4 ± 6.5 | 97.5 ± 5.1 | 0.88 |
| HbA1c (%) | 5.38 ± 0.31 | 5.37 ± 0.23 | 0.98 |
| Creatinine (mg/dL) | 0.70 ± 0.14 | 0.73 ± 0.11 | 0.28 |